The importance of TAMs in CHL is exemplified by several reports indicating that primary treatment failure and decreased overall survival of adult CHL patients is associated with TAM density, measured by CD68, CD163 or colony-stimulating factor 1 receptor (CSF1R) immunoreactivity in diagnostic lymph node specimens [3–8]. The gene discussed is CD68; the disease is classic Hodgkin lymphoma.